UNSPSC 85543070: Occlusion of left axillary lymphatic with extraluminal device, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to occlusion of left axillary lymphatic with extraluminal device, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 07L63CZ

UNSPSC 85543070, Occlusion of left axillary lymphatic with extraluminal device, percutaneous approach, is a Commodity code that carries a medical-device procedural classification with minimal alignment to state and local government procurement activity. The recent opportunities tagged under this code reflect unrelated health-care service sourcing—specifically independent medical evaluations, pharmacy benefit management, occupational health surveillance, surgical carve-out networks, youth detention medical services, and temporary clinical staffing—none of which involve lymphatic-occlusion devices or the interventional procedure the code nominally describes. State and local health authorities, counties, cities, and specialized boards are using this code incorrectly or as a catch-all for health-services procurement regardless of clinical modality, indicating either a cataloging error in the sourcing system or a mislabeling of opportunities at the point of posting.

Activity appears concentrated among a small set of jurisdictions: the City of Phoenix (disability medical evaluations for public safety pension boards), the City of Long Beach (surgical benefit carve-out programs), Washington State Department of Transportation/Ferries (occupational medical surveillance), Harris County Juvenile Probation Department (emergency and specialty care for detained youth), Collier County (pharmacy benefit management), and Santa Clara County Health System (temporary clinical staffing across multiple ancillary categories). The geographic spread spans Arizona, California, Florida, and Washington, with no standout repeat buyer pattern. Given the code's nominal scope and the nature of recent postings, this code does not meaningfully represent actual state and local procurement of lymphatic-occlusion devices or related interventional procedures; firms pursuing medical-device business in state and local markets should not rely on this code for opportunity identification and should verify code application directly with issuing bodies before pursuing individual solicitations.